tiprankstipranks
Trending News
More News >
Immunome, Inc. (IMNM)
:IMNM
US Market

Immunome (IMNM) Income Statement

Compare
354 Followers

Immunome Income Statement

Last quarter (Q3 2025), Immunome's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Immunome's net income was $-57.46M. See Immunome’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.04M$ 14.02M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 9.04M$ 14.02M$ 0.00$ 0.00$ -755.00K
Operating Expenses
$ 314.84M$ 123.55M$ 36.90M$ 25.20M$ 11.51M
Depreciation and Amortization
$ 2.10M$ 728.00K$ 631.00K$ 755.00K$ 755.00K
EBITDA
$ -151.35M$ -28.00M$ -36.27M$ -24.45M$ -17.04M
Operating Income
$ -305.80M$ -109.53M$ -36.90M$ -25.20M$ -12.26M
Other Income/Expenses
$ 12.84M$ 2.72M$ 5.00K$ 493.00K$ -5.58M
Pretax Income
$ -292.96M$ -106.81M$ -36.90M$ -24.71M$ -17.84M
Net Income
$ -292.96M$ -106.81M$ -36.90M$ -24.71M$ -17.84M
Per Share Metrics
Basic EPS
$ -5.00$ -5.38$ -3.09$ -2.14$ -1.69
Diluted EPS
$ -5.00$ -5.38$ -3.09$ -2.14$ -1.69
Weighted Average Shares Outstanding
58.64M 19.84M 12.13M 11.54M 10.11M
Weighted Average Shares Outstanding (Diluted)
58.64M 19.84M 12.13M 11.54M 10.11M
Currency in USD

Immunome Earnings and Revenue History